{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:50:36Z","timestamp":1792842636374,"version":"4.5.0"},"reference-count":18,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2013,10]]},"abstract":"\n Object<\/jats:title>\n The objective of the present study was to perform a prospective evaluation of the potential efficacy and safety of intraoperative photodynamic therapy (PDT) using talaporfin sodium and irradiation using a 664-nm semiconductor laser in patients with primary malignant parenchymal brain tumors.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n In 27 patients with suspected newly diagnosed or recurrent primary malignant parenchymal brain tumors, a single intravenous injection of talaporfin sodium (40 mg\/m\n 2<\/jats:sup>\n ) was administered 1 day before resection of the neoplasm. The next day after completion of the tumor removal, the residual lesion and\/or resection cavity were irradiated using a 664-nm semiconductor laser with a radiation power density of 150 mW\/cm\n 2<\/jats:sup>\n and a radiation energy density of 27 J\/cm\n 2<\/jats:sup>\n . The procedure was performed 22\u201327 hours after drug administration. The study cohort included 22 patients with a histopathologically confirmed diagnosis of primary malignant parenchymal brain tumor. Thirteen of these neoplasms (59.1%) were newly diagnosed glioblastomas multiforme (GBM).\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among all 22 patients included in the study cohort, the 12-month overall survival (OS), 6-month progression-free survival (PFS), and 6-month local PFS rates after surgery and PDT were 95.5%, 91%, and 91%, respectively. Among patients with newly diagnosed GBMs, all these parameters were 100%. Side effects on the skin, which could be attributable to the administration of talaporfin sodium, were noted in 7.4% of patients and included rash (2 cases), blister (1 case), and erythema (1 case). Skin photosensitivity test results were relatively mild and fully disappeared within 15 days after administration of photosensitizer in all patients.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n Intraoperative PDT using talaporfin sodium and a semiconductor laser may be considered as a potentially effective and sufficiently safe option for adjuvant management of primary malignant parenchymal brain tumors. The inclusion of intraoperative PDT in a combined treatment strategy may have a positive impact on OS and local tumor control, particularly in patients with newly diagnosed GBMs. Clinical trial registration no.: JMA-IIA00026 (\n https:\/\/dbcentre3.jmacct.med.or.jp\/jmactr\/App\/JMACTRS06\/JMACTRS06.aspx?seqno=862<\/jats:ext-link>\n ).\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2013.7.jns13415","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T10:04:08Z","timestamp":1376647448000},"page":"845-852","source":"Crossref","is-referenced-by-count":232,"title":["Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors"],"prefix":"10.3171","volume":"119","author":[{"given":"Yoshihiro","family":"Muragaki","sequence":"first","affiliation":[{"name":"Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, and"},{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Akimoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical University, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, and"},{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iseki","sequence":"additional","affiliation":[{"name":"Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, and"},{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soko","family":"Ikuta","sequence":"additional","affiliation":[{"name":"Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nitta","sequence":"additional","affiliation":[{"name":"Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, and"},{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Maebayashi","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Tokyo Women's Medical University, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiichi","family":"Saito","sequence":"additional","affiliation":[{"name":"Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, and"},{"name":"Department of Neurosurgery, Hiroshima University, Hiroshima;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Okada","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadao","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Kashiwaba Neurosurgical Hospital, Sapporo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Tsukuba, Ibaragi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Kuroiwa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka Medical College, Osaka;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Karasawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Gunma University Graduate School of Medicine, Gunma; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Kayama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yamagata University, Yamagata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns13415","series-title":"Photodiagn Photodyn Ther","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pdpdt.2012.01.001","article-title":"Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas","volume":"9","author":"Akimoto","year":"2012"},{"key":"b2-jns13415","series-title":"Cancer Treat Rev","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.03.009","article-title":"Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies","author":"Bechet","year":"2012"},{"key":"b3-jns13415","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.03.009"},{"key":"b4-jns13415","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.pdpdt.2012.01.001","article-title":"Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies","volume":"19","author":"Colditz","year":"2012"},{"issue":"Suppl","key":"b5-jns13415","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/85.9.704","article-title":"Report of brain tumor registry of Japan (1984\u20132000), 12 edition","volume":"49","author":"Committee of Brain Tumor Registry of Japan","year":"2009"},{"key":"b6-jns13415","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/jnci\/90.12.889","article-title":"Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials","volume":"85","author":"Curran","year":"1993"},{"key":"b7-jns13415","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1039\/b705461k","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998"},{"key":"b8-jns13415","series-title":"Photochem Photobiol Sci","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2176\/nmc.52.577","article-title":"Milestones in the development of photodynamic therapy and fluorescence diagnosis","volume":"6","author":"Juzeniene","year":"2007"},{"key":"b9-jns13415","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/978-1-60761-697-9_17","article-title":"Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant management: retrospective analysis of 43 cases","volume":"52","author":"Konishi","year":"2012"},{"key":"b10-jns13415","series-title":"Methods Mol Biol","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-60761-697-9_17","article-title":"Photodynamic diagnosis and therapy and the brain","volume":"635","author":"Kostron","year":"2010"},{"key":"b11-jns13415","series-title":"WHO Classification of Tumours of the Central Nervous System","doi-asserted-by":"publisher","year":"2007","DOI":"10.1007\/s10103-007-0469-3"},{"key":"b12-jns13415","series-title":"Lasers Med Sci","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1248\/bpb.b12-00567","article-title":"Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma","volume":"23","author":"Matsumura","year":"2008"},{"key":"b13-jns13415","series-title":"Biol Pharm Bull","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.pdpdt.2008.08.001","article-title":"Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells","volume":"36","author":"Miki","year":"2013"},{"key":"b14-jns13415","series-title":"Photodiagn Photodyn Ther","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1517\/17425247.4.2.131","article-title":"Photodynamic therapy of C6-implanted glioma cells in the rat brain employing second-generation photosensitizer talaporfin sodium","volume":"5","author":"Namatame","year":"2008"},{"key":"b15-jns13415","series-title":"Expert Opin Drug Deliv","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11060-012-0983-4","article-title":"Photodynamic therapy and cancer: a brief sightseeing tour","volume":"4","author":"Palumbo","year":"2007"},{"key":"b16-jns13415","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma","volume":"111","author":"Petrecca","year":"2013"},{"key":"b17-jns13415","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1056\/NEJMoa043330","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006"},{"key":"b18-jns13415","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.pdpdt.2012.01.001","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/119\/4\/article-p845.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/119\/4\/article-p845.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/119\/4\/article-p845.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T13:23:53Z","timestamp":1660483433000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/119\/4\/article-p845.xml"}},"subtitle":["Clinical article"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":18,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2013.7.jns13415","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}